2024

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of  Ingredients through Botanical Synthesis Technology

   New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages        December 11, 2024 – London, UK and Vancouver, Canada – Tate & Lyle PLC(‘Tate & Lyle’), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ:BHST) (CSE:BHSC) (‘BioHarvest’), leaders in Botanical Synthesis, announce […]

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of  Ingredients through Botanical Synthesis Technology Read More »

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel – November 25, 2024 – BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for

BioHarvest Sciences Reports Third Quarter 2024 Financial Results Read More »

BioHarvest Launches VINIA SuperFood Functional Tea Line

Incremental Product Launch Addresses $3.3  Billion North American Functional Tea Market Opportunity with First SuperFood Tea Infused with Piceid Resveratrol Vancouver, British Columbia and Rehovot, Israel – November 25, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0), a company pioneering its patented Botanical Synthesis technology platform, today announced

BioHarvest Launches VINIA SuperFood Functional Tea Line Read More »

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Vancouver, British Columbia and Rehovot, Israel – November 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV), a company pioneering its patented Botanical Synthesis technology platform, today announcedthat management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024 Read More »

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 p.m. Eastern Time

Vancouver, British Columbia and Rehovot, Israel – November 18, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024. Management

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 p.m. Eastern Time Read More »

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Vancouver, British Columbia and Rehovot, Israel – November 12, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company’s shares will begin trading on the Nasdaq Global Market (“Nasdaq”) at the opening of the U.S. market today under the

BioHarvest Sciences Begins Trading on the Nasdaq Global Market Read More »